Shionogi & Co., Ltd.
General ticker "SGIOF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $4.5B (TTM average)
Shionogi & Co., Ltd. follows the US Stock Market performance with the rate: 24.8%.
Estimated limits based on current volatility of 0.2%: low 15.16$, high 15.23$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.22$ (Y1.45%)
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [11.69$, 16.84$]
- 2026-03-31 to 2027-03-31 estimated range: [11.78$, 17.10$]
Financial Metrics affecting the SGIOF estimates:
- Positive: with PPE of 8.0 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 35.73 > 18.64
- Positive: Operating cash flow per share per price, % of 30.24 > 13.24
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: 0.79 < Interest expense per share per price, % of 1.40
- Negative: 0 < Inventory ratio change, % of 0.01
- Positive: Shareholder equity ratio, % of 88.70 > 63.39
- Positive: Industry inventory ratio change (median), % of -1.45 <= -0.15
- Negative: Investing cash flow per share per price, % of -17.96 <= -14.38
- Negative: negative Industry operating income (median)
Short-term SGIOF quotes
Long-term SGIOF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥426,684.00MM | ¥435,081.00MM | ¥438,268.00MM |
| Operating Expenses | ¥277,681.00MM | ¥281,771.00MM | ¥281,665.00MM |
| Operating Income | ¥149,003.00MM | ¥153,310.00MM | ¥156,603.00MM |
| Non-Operating Income | ¥71,329.00MM | ¥44,973.00MM | ¥44,147.00MM |
| Interest Expense | ¥4,500.00MM | ¥6,701.00MM | ¥9,027.00MM |
| R&D Expense | ¥102,392.00MM | ¥102,640.00MM | ¥108,612.00MM |
| Income(Loss) | ¥220,332.00MM | ¥198,283.00MM | ¥200,750.00MM |
| Taxes | ¥35,836.00MM | ¥37,708.00MM | ¥31,215.00MM |
| Profit(Loss)* | ¥184,965.00MM | ¥162,030.00MM | ¥170,435.00MM |
| Stockholders Equity | ¥1,100,046.00MM | ¥1,235,326.00MM | ¥1,361,924.00MM |
| Inventory | ¥57,919.00MM | ¥64,916.00MM | ¥65,477.00MM |
| Assets | ¥1,311,800.00MM | ¥1,416,918.00MM | ¥1,535,349.00MM |
| Operating Cash Flow | ¥177,867.00MM | ¥154,284.00MM | ¥195,460.00MM |
| Capital expenditure | ¥37,187.00MM | ¥28,267.00MM | ¥52,103.00MM |
| Investing Cash Flow | ¥-48,292.00MM | ¥5,922.00MM | ¥-116,080.00MM |
| Financing Cash Flow | ¥-84,123.00MM | ¥-126,853.00MM | ¥-64,908.00MM |
| Earnings Per Share** | ¥621.31 | ¥558.32 | ¥600.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.